ABG Innovation Capital Partners III GP as of Dec. 31, 2020
Portfolio Holdings for ABG Innovation Capital Partners III GP
ABG Innovation Capital Partners III GP holds 7 positions in its portfolio as reported in the December 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Atea Pharmaceuticals (AVIR) | 64.9 | $110M | 2.6M | 41.78 | |
| Pulmonx Corp (LUNG) | 33.9 | $58M | 833k | 69.02 | |
| Genocea Biosciences Com New (GNCAQ) | 0.5 | $908k | 375k | 2.42 | |
| Synlogic | 0.3 | $445k | 206k | 2.16 | |
| Aerpio Pharmaceuticals | 0.2 | $392k | 400k | 0.98 | |
| Idera Pharmaceuticals Com Par | 0.1 | $206k | 56k | 3.66 | |
| Nabriva Therapeutics Shs New | 0.1 | $111k | 46k | 2.42 |
